Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-10
2008-09-02
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S414000, C514S419000
Reexamination Certificate
active
07419992
ABSTRACT:
A method of treating angiogenesis-implicated disorders by selecting a subject predisposed to an angiogenesis-implicated disorder and then administering an effective amount of an endogenous aryl hydrocarbon receptor ligand or its analogs according to a formula as disclosed herein is disclosed.
REFERENCES:
patent: 3285931 (1966-11-01), Husigen
patent: 6323228 (2001-11-01), BaMaung
patent: 11269175 (1999-10-01), None
patent: WO 94/02483 (1994-02-01), None
Pandya et al. Vascular Pharmacology, vol. 44, (2006), p. 265-274.
Adachi J, et al. “Indirubin and indigo are potent aryl hydrocarbon receptor ligand present in human urine,” J. Biol. Chem. 276:31475-31478 (2001).
Chen I, et al., “Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells,” Biochem. Pharmacol. 51:1069-1076 (1996).
Chen Y, et al., “Regulation of CYP1A1 by indolo[3,2-b]carbazole in murine hepatoma cells,” J. Biol. Chem. 270:22548-22555 (1995).
Cheung Y, et al., “Interaction with the aromatic hydrocarbon receptor, cyp1a induction, and mutagenicity of a series of diaminotoluenes—implications for their carcinogenicity,” Toxicol. Appl. Pharmacol. 139:203-211 (1996).
Garrison P, et al., “Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals,” Fund. Appl. Toxicol. 30:194-203 (1996).
Heathpagliuso S, et al. “Activation of the Ah receptor by tryptophan and tryptophan metabolites,” Biochem. 37:11508-11515 (1998).
Jellinck P, et al., “Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation,”. Biochem. Pharmacol. 45:1129-1136 (1993).
Kleman M, et al., “Regulation of human dioxin receptor function by indolocarbazoles, receptor ligands of dietary origin,”. J. Biol. Chem. 269:5137-5144 (1994).
Lee I, et al., “Transcriptional induction of the cytochrome p4501a1 gene by a thiazolium compound, yh439,” Mol. Pharmacol. 49:980-988 (1996).
Liu R, et al., “Regulation of [Ah] gene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2-b]indole in mouse hepatoma cell lines,” Carcinogenesis. 15:2347-2352 (1994).
Phelan D, et al. “Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin,” Arc. Biochem. Biophy. 357:155-163 (1998).
Poellinger L, “Mechanistic aspects-the dioxin (aryl hydrocarbon) receptor,” Food Add. Contam. 17:261-266 (2000).
Poland A & Glover E, “Chlorinated dibenzo-p-dioxin: Potent inducers of delta-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. II. A study of the structure-activity relationship,” Mol. Pharmacol. 9:736-747 (1973).
Rannung A, et al., “Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances,” J. Biol. Chem. 262:15422-15427 (1987).
Schaldach C, et al., “Lipoxin A(4): A new class of ligand for the Ah receptor,” Biochem. 38:7594-7600 (1999).
Sinal C & Bend, J, “Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells,” Mol. Pharmacol. 52(4):590-599 (1997).
Stephensen P,et al., “N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol,” Nutr Cancer Internatl. J. 36(1):112-121 (2000).
Vasiliou V, “Response of [Ah] battery genes to compounds that protect against menadione toxicity,” Biochem. Pharmacol. 50(11):1885-1891 (1995).
Washburn B, et al. “Brevetoxin-6 (pbtx-6), a nonaromatic marine neurotoxin, is a ligand of the aryl hydrocarbon receptor,” Arc. Biochem. Biophy. 343(2):149-156 (1997).
Whitlock J, “Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action,” Ann. Rev. Pharmacol. Toxicol. 30:251-277 (1990).
North M & Pattenden G, “Synthetic studies towards cyclic peptides. Concise synthesis of thiazoline and thiazole containing amino acids,” Tetrahedron 46:8267-8290 (1990).
Akhtar Nasim
Clagett-Dame Margaret
DeLuca Hector F.
Helfand Stuart
Song Jiasheng
Anderson Rebecca L
Chu Yong
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
LandOfFree
Use of aryl hydrocarbon receptor ligand as a therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of aryl hydrocarbon receptor ligand as a therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of aryl hydrocarbon receptor ligand as a therapeutic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3984171